Very Early Interventions in Psychotic Disorders

Psychiatric Clinics of North America

Volumn 32, Issue 1, 2009, Pages 81-94

  Bhangoo, Robinder K ^a   Carter, Cameron S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Early intervention; Prodromal; Psychosis; Ultra high risk

Indexed keywords

AMISULPRIDE; CANNABIS; CATECHOL METHYLTRANSFERASE; CHLORPROMAZINE; OLANZAPINE;

ADOLESCENT; ARTICLE; CASE REPORT; DELUSION; DETERIORATION; DISEASE COURSE; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; HIGH RISK PATIENT; HUMAN; LABORATORY DIAGNOSIS; MAJOR DEPRESSION; MALE; OUTCOMES RESEARCH; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RISK FACTOR; SCHIZOPHRENIA;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ADULT; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 60549108573     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2008.10.003     Document Type: Article

References (67)

1. Meares A. The diagnosis of prepsychotic schizophrenia. Lancet 1 (1959) 55-58
2. Yung A.R., and McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22 2 (1996) 353-370
3. Cameron E.D. Early schizophrenia. Am J Psychiatry 95 (1938) 567-578
4. Varsamis J., and Adamson J.D. Early schizophrenia. Can Psychiatr Assoc J 16 (1971) 487-497
5. In: Conrad K. (Ed). Die beginnende schizophrenie (1958), Georg Thieme Verlag, Stuttgart, Germany
6. Beiser M., Erickson D., Fleming J.A.E., et al. Establishing the onset of psychotic illness. Am J Psychiatry 150 (1993) 1349-1354
7. Cornblatt B.A., Lencz T., Obuchowski M., et al. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Res 54 (2002) 177-186
8. Cornblatt B.A., Lencz T., Smith C.W., et al. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 29 (2003) 633-651
9. Phillips L.J., Yung A.R., Yuen H.P., et al. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am J Med Genet 114 (2002) 929-937
10. McGorry P.D., and Singh B.S. Schizophrenia: risk and possibility. In: Raphael B., and Burrows G.D. (Eds). Handbook of studies on preventive psychiatry (1995), Elsevier, Amsterdam 491-514
11. Gross G. The onset of schizophrenia. Schizophr Res 28 (1997) 187-198
12. Koehler K., and Sauer H. Huber's basic symptoms: another approach to negative psychopathology in schizophrenia. Compr Psychiatry 25 2 (1984) 174-182
13. Klosterkotter J., Ebel H., Schultze-Lutter F., et al. Diagnostic validity of basic symptoms. Eur Arch Psychiatry Clin Neurosci 246 (1996) 147-154
14. Klosterkotter J., Hellmich M., Steinmeyer E.M., et al. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58 (2001) 158-164
15. Bell R.Q. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry 55 (1992) 370-381
16. Sullivan H.S. The onset of schizophrenia. Am J Psychiatry 6 (1927) 105-134
17. Yung A.R., Phillips L.J., Yuen H.P., et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 60 (2003) 21-32
18. Meyer S.K., Bearden C.E., Lux S.R., et al. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol 15 3 (2005) 434-451
19. Svirskis T., Korkeila J., Heinimaa M., et al. Axis-I disorders and vulnerability to psychosis. Schizophr Res 75 (2005) 439-446
20. Yung A.R., Buckby J.A., Cosgrave E.M., et al. Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophr Res 91 (2007) 246-253
21. Andreasson S., Allebeck P., Engstrom A., et al. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2 (1987) 1483-1486
22. Zammit S., ALlebeck P., Andreasson S., et al. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 325 (2002) 1199-1203
23. Arseneault L., Cannon M., Poulton R., et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 325 (2002) 1212-1213
24. Van Os J., Bak M., Hanssen M., et al. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156 (2002) 319-327
25. Fergusson D.M., Horwood J.L., and Swain-Campbell N.R. Cannabis dependence and psychotic symptoms in young people. Psychol Med 33 (2003) 15-21
26. Henquet C., Krabbendam L., Spauwen J., et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330 (2005) 11-16
27. Moore T.H.M., Zammit S., Lingford-Hughes A., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370 (2007) 319-328
28. Veen N.D., Selten J.P., Van der Tweel I., et al. Cannabis use and age at onset of schizophrenia. Am J Psychiatry 161 (2004) 501-506
29. Meyer-Lindenberg A., Nichols T., Callicott J.H., et al. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 11 (2006) 867-877
30. Caspi A., Moffitt T.E., Cannon M., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry 57 (2005) 1117-1127
31. Perkins D.O., Gu H., Boteva K., et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162 10 (2005) 1785-1804
32. Marshall M., Lewis S., Lockwood A., et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 62 (2005) 975-983
33. Larsen T.K., Melle I., Auestad B., et al. Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull 32 4 (2006) 758-764
34. Melle I., Larsen T.K., Haahr U., et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 61 (2004) 143-150
35. Melle I., Johannesen J.O., Friis S., et al. Early detection of the first episode of schizophrenia and suicidal behavior. Am J Psychiatry 163 5 (2006) 800-804
36. Melle I., Larsen T.K., Haahr U., et al. Prevention of negative symptom psychopathologies in first-episode schizophrenia. Arch Gen Psychiatry 65 6 (2008) 634-640
37. Thorup A., Petersen L., Jeppesen P., et al. Integrated treatment ameliorates negative symptoms in first episode psychosis-results from the Danish OPUS trial. Schizophr Res 79 (2005) 95-105
38. Petersen L., Nordentoft M., Jeppesen P., et al. Improving 1-year outcome in first-episode psychosis. Br J Psychiatry 187 48 (2005) s98-s103
39. Bertelsen M., Jeppesen P., Petersen L., et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness. Arch Gen Psychiatry 65 7 (2008) 762-771
40. Craig T.K.J., Garety P., Power P., et al. The Lambeth early onset (LEO) team: randomized controlled trial of the effectiveness of specialized care for early psychosis. Br Med J 329 7474 (2004) 1067
41. Mihalopoulos C., McGorry P.D., and Carter R.C. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatr Scand 100 1 (1999) 47-55
42. Culberg J., Mattsson M., Levander S., et al. Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish "parachute project" and two comparison groups. Acta Psychiatr Scand 114 4 (2006) 274-281
43. Miller T.J., McGlashan T.H., Woods S.W., et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 70 (1999) 273-287
44. McGlashan T.H., Miller T.J., Woods S.W., et al. A scale for the assessment of prodromal symptoms and states. In: Miller T.J., Mednick S.A., McGlashan T.H., et al. (Eds). Early intervention in psychotic disorders (2001), Kluwer Academic Publishers, Dordrecht, The Netherlands 135-149
45. Hawkins K.A., Quinlan D., Miller T.J., et al. Factorial structure of the scale of prodromal symptoms. Schizophr Res 68 2-3 (2004) 339-347
46. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th edition (1994), APA, Washington, DC
47. Andreasen N.C., Endicott J., Spitzer R.L., et al. The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 34 (1977) 1229-1235
48. Hall R. Global assessment of functioning: a modified scale. Psychosomatics 36 (1995) 267-275
49. Miller T.J., McGlashan T.H., Rosen J.L., et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29 4 (2003) 703-715
50. Yung A.R., McGorry P.D., Francey S.M., et al. PACE: a specialized service for young people at risk of psychotic disorders. Med J Aust 187 7 (2007) s43-s46
51. Yung A.R., Phillips L.J., Yuen H.P., et al. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67 (2004) 131-142
52. Miller T.J., McGlashan T.H., Rosen J.L., et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159 (2002) 863-865
53. Mason O., Startup M., Halpin S., et al. State and trait predictors of transition to first episode psychosis among individuals with at risk mental states. Schizophr Res 71 (2004) 227-237
54. Larsen T.K. The transition from premorbid period to psychosis: how can it be described?. Acta Psychiatr Scand 106 (2002) s10-s11
55. Yung A.R., Yuen H.P., Berger G., et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk. Schizophr Bull 33 3 (2007) 673-681
56. French P., Shryane N., Bentall R.P., et al. Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis. Br J Psychiatry 191 (2007) s82-s87
57. Morrison A.P., French P., Parker S., et al. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 33 3 (2007) 682-687
58. Woods S.W., Tully E.M., Walsh B.C., et al. Aripiprazole in the treatment of the psychosis prodrome. Br J Psychiatry 191 (2007) s96-s101
59. Ruhrmann S., Bechdolf A., Kuhn K.-U., et al. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry 191 (2007) s88-s95
60. Cornblatt B.A., Lencz T., Smith C.W., et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 68 (2007) 546-557
61. McGlashan T.H., Zipursky R.B., Perkins D., et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163 (2006) 790-799
62. Cannon T.D., Cadenhead K., Cornblatt B., et al. Prediction of psychosis in youth at high clinical risk. Arch Gen Psychiatry 65 1 (2008) 28-37
63. Wood S.J., Brewer W.J., Koutsouradis P., et al. Cognitive decline following psychosis onset. Br J Psychiatry 191 (2007) s52-s57
64. Pantelis C., Velakoulis D., McGorry P.D., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 (2003) 281-288
65. Borgwardt S.J., Riecher-Rossler A., Dazzan P., et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61 (2007) 1148-1156
66. Fornito A., Yung A.R., Wood S.J., et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry 64 9 (2008) 758-765
67. Waterfang M., Yung A.R., Wood A.G., et al. Corpus callosum shape alterations in individuals prior to the onset of psychosis. Schizophr Res 103 1-3 (2008) 1-10